HIV INFECTION
Clinical trials for HIV INFECTION explained in plain language.
Never miss a new study
Get alerted when new HIV INFECTION trials appear
Sign up with your email to follow new studies for HIV INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Scientists test four different HIV vaccine recipes in search for protection
⭐️ VACCINE ⭐️ CompletedThis study tested four different combinations of experimental HIV vaccines in healthy volunteers to see which approach was safest and best at triggering an immune response. Ninety-two participants at low risk of HIV infection received different sequences of vaccine shots over sev…
Matched conditions: HIV INFECTION
Phase: PHASE1, PHASE2 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 04, 2026 00:35 UTC
-
Scientists test if One-Time antibody shot lets HIV patients live without daily pills
Disease control CompletedThis study tested whether people who received an experimental antibody (VRC01) before getting HIV could better control the virus without needing daily medication. Thirteen participants who had been taking HIV drugs for at least a year temporarily stopped their medication under ve…
Matched conditions: HIV INFECTION
Phase: NA • Sponsor: HIV Vaccine Trials Network • Aim: Disease control
Last updated Apr 04, 2026 00:36 UTC
-
New HIV pill shows promise in major trial
Disease control CompletedThis study tested if people with well-controlled HIV could safely switch from their current daily medications to a new, single once-daily pill containing two drugs, doravirine and islatravir. It involved 672 participants whose virus was already suppressed. The main goal was to se…
Matched conditions: HIV INFECTION
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New Two-Drug HIV pill tested as potential simpler treatment
Disease control CompletedThis study tested if people with well-controlled HIV could safely switch from a standard three-drug daily pill to a new two-drug daily pill. Researchers compared the new combination (doravirine/islatravir) against continuing the original treatment to see if it kept the virus supp…
Matched conditions: HIV INFECTION
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
One pill for all: new hope for children with HIV in africa
Disease control CompletedThis study tested a new dose of three proven HIV medicines (dolutegravir, emtricitabine, and tenofovir alafenamide) in children under 10 years old in Africa. The goal was to find the right dose to create a single, easy-to-take tablet that works for all children, just like adults.…
Matched conditions: HIV INFECTION
Phase: PHASE2 • Sponsor: PENTA Foundation • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Video exercise program may turn back the clock for veterans with HIV
Disease control CompletedThis study tested whether a 12-week, high-intensity exercise program delivered by video could slow down the accelerated aging process seen in older Veterans living with HIV. Researchers enrolled 89 Veterans over age 50 with stable HIV to see if the no-equipment circuit training c…
Matched conditions: HIV INFECTION
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
Personal guides tested to boost HIV prevention pill use in malawi
Prevention CompletedThis study tested whether having a personal guide, called a systems navigator, could help men in Malawi stick with their HIV prevention medication (PrEP) for six months. The study involved 199 heterosexual men who were already seeking care for other sexually transmitted infection…
Matched conditions: HIV INFECTION
Phase: NA • Sponsor: HIV Prevention Trials Network • Aim: Prevention
Last updated Apr 03, 2026 14:42 UTC
-
Vaccine trial aims to shield HIV+ women from cervical cancer risk
Prevention CompletedThis study tested whether the HPV vaccine could help prevent high-grade cervical lesions from developing or returning in women living with HIV. 536 HIV-positive women who also had HPV received either the actual vaccine or a placebo (saltwater shot) after their cervical lesions we…
Matched conditions: HIV INFECTION
Phase: PHASE3 • Sponsor: AIDS Malignancy Consortium • Aim: Prevention
Last updated Mar 30, 2026 14:28 UTC
-
Scientists track children for 7 years to unlock HIV cure clues
Knowledge-focused CompletedThis study is observing children who started HIV medication within weeks of birth to understand their long-term health, immune system, and virus levels. About 250 children will be followed for up to seven years with regular check-ups and sample collection. The goal is to gather d…
Matched conditions: HIV INFECTION
Sponsor: International Maternal Pediatric Adolescent AIDS Clinical Trials Group • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC
-
Scientists hunt for immune clues in deadly lung pressure disease
Knowledge-focused CompletedThis study aimed to understand how the body's own immune system might be involved in causing or worsening pulmonary arterial hypertension (PAH), a serious condition of high blood pressure in the lungs. Researchers compared blood samples from over 600 people, including patients wi…
Matched conditions: HIV INFECTION
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:15 UTC
-
Hidden kidney trouble in HIV patients?
Knowledge-focused CompletedThis study aimed to understand if HIV infection causes hidden problems with how the kidneys process water, even when standard blood and urine tests appear normal. Researchers compared 30 adults with HIV to people without HIV using a special kidney function test. The goal was to g…
Matched conditions: HIV INFECTION
Sponsor: Hospital Italiano de Buenos Aires • Aim: Knowledge-focused
Last updated Mar 02, 2026 15:21 UTC